More about

Non-Alcoholic Fatty Live Disease

News
June 15, 2023
1 min read
Save

FDA grants fast track designation to Merck’s efinopegdutide for treatment of NASH

The FDA granted fast track designation to efinopegdutide for the treatment of nonalcoholic steatohepatitis, according to a manufacturer’s press release.

News
March 23, 2023
3 min read
Save

Steatosis present in most adults with type 1 diabetes and overweight or obesity

Hepatic steatosis may be present in most adults with type 1 diabetes, especially those with overweight or obesity, according to a study published in Journal of Diabetes and Its Complications.

News
December 02, 2022
3 min read
Save

Fatty liver disease conditions ‘change the healthy heart to a failing heart’

CVD risk increases with the severity of nonalcoholic fatty liver disease, and both CV and liver events are “highly related” to the degree of hepatic fibrosis present, according to a speaker.

News
August 30, 2022
2 min read
Save

Evening chronotype associated with more severe NAFLD for adults with obesity

Evening chronotype was associated with more severe nonalcoholic fatty liver disease independent of age, sex and BMI compared with morning chronotype among adults with obesity, according to data published in International Journal of Obesity.

News
August 19, 2022
1 min read
Save

Top news from ENDO: hair care EDCs, cell phone-obesity link, AI thyroid diagnosis and more

The Healio and Endocrine Today editors have compiled the most read news from the Endocrine Society annual meeting in June.

News
June 29, 2022
1 min read
Save

Top in endocrinology: Nonalcoholic fatty liver disease in patients with obesity, diabetes

In a recent study, adults with overweight or obesity and nonalcoholic fatty liver disease who received daily subcutaneous growth hormone had a significant reduction in liver fat and inflammation compared with those who received placebo.

News
June 23, 2022
1 min read
Save

Thyroid hormone levels linked to liver fibrosis in type 2 diabetes

Among patients with type 2 diabetes and normal thyroid function, thyroid hormone levels were linked to nonalcoholic fatty liver disease, suggesting assessment of these hormones might be beneficial for disease prevention and treatment.

News
June 23, 2022
2 min read
Save

Growth hormone reduces liver fat, inflammation in adults with NAFLD

ATLANTA — Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration, according to a speaker.

News
June 07, 2022
7 min watch
Save

VIDEO: New tools help to individualize obesity, comorbidity treatment

NEW ORLEANS — In the third part of this video exclusive, James R. Gavin III, MD, PhD, talks with Jamy D. Ard, MD, about new drugs for substantial weight loss and treatment of obesity-related comorbidities, including type 2 diabetes and liver disease.

News
May 13, 2022
2 min read
Save

Liver fat percentage does not alter risk for CV events

SAN DIEGO — Liver fat content is not associated with risk for any cardiovascular event, according to data from the Dallas Heart Study presented at the AACE Annual Scientific and Clinical Conference.

View more